| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.003 | 1 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.00094 | 1 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.00085 | 1 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.00067 | 1 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.0005 | 1 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.00039 | 1 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0004 | 1 |